Search Results - "Carter, Leslie"
-
1
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
Published in Diabetes (New York, N.Y.) (01-03-2003)“…Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy Susan A. Phillips 1 2 , Theodore P. Ciaraldi 1 3 , Alice P.S. Kong 1 3…”
Get full text
Journal Article -
2
Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle
Published in Diabetes (New York, N.Y.) (01-07-2002)“…Inhibition of Glycogen Synthase Kinase 3 Improves Insulin Action and Glucose Metabolism in Human Skeletal Muscle Svetlana E. Nikoulina 1 2 , Theodore P…”
Get full text
Journal Article -
3
Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects
Published in American journal of physiology: endocrinology and metabolism (01-08-2003)“…We examined the regulation of free fatty acid (FFA, palmitate) uptake into skeletal muscle cells of nondiabetic and type 2 diabetic subjects. Palmitate uptake…”
Get more information
Journal Article -
4
Effects of emotion on pain reports, tolerance and physiology
Published in Pain research & management (2002)“…The effects of specific emotional states on a laboratory pain task were tested by examining the behavioural, verbal and psychophysiological responses of 80…”
Get full text
Journal Article -
5
Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection
Published in Journal of the American College of Cardiology (01-03-2016)“…Abstract Background The BRUISE CONTROL trial (Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial) demonstrated that a strategy of…”
Get full text
Journal Article -
6
Insulin and insulin-like growth factor-1 action on human skeletal muscle: Preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects
Published in Metabolism, clinical and experimental (01-09-2002)“…The metabolic actions of insulin and insulin-like growth factor-1 (IGF-1) were compared in cultured skeletal muscle cells from nondiabetic (ND) and type 2…”
Get full text
Journal Article -
7
Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study
Published in Journal of the American College of Cardiology (22-03-2016)“…The BRUISE CONTROL trial (Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial) demonstrated that a strategy of continued warfarin during…”
Get full text
Journal Article -
8
267-OR: ADA Presidents' Select Abstract: Combining an SGLT Inhibitor with a Glucagon Receptor Agonist (GRA) in Subjects with Type 1 Diabetes—A Randomized Clinical Trial
Published in Diabetes (New York, N.Y.) (20-06-2023)“…SGLTi treatment improves glycemic control and reduces insulin dosing but increases the risk of diabetic ketoacidosis (DKA). Combination therapy (SGLTi + GRA)…”
Get full text
Journal Article -
9
128-LB: Effects of Glucagon Receptor Antagonism (GRA) on Ketone Body Formation during Insulinopenia in Type 1 Diabetes (T1D)
Published in Diabetes (New York, N.Y.) (01-06-2020)“…Background: Diabetic ketoacidosis is a common and life-threatening complication of T1D. Glucagon stimulates ketogenesis via peripheral lipolysis and hepatic…”
Get full text
Journal Article -
10
Canadian Hospital Food Service Practices to Prevent Malnutrition
Published in Canadian journal of dietetic practice and research (01-12-2021)“…The study aimed to determine current practice, barriers, and enablers of foodservices in Canadian hospitals relative to guiding principles for best practice to…”
Get more information
Journal Article -
11
Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance
Published in Diabetologia (01-10-2017)“…Aims/hypothesis Mitochondria are important regulators of the metabolic phenotype in type 2 diabetes. A key factor in mitochondrial physiology is the H + -ATP…”
Get full text
Journal Article -
12
322-OR: SGLT2 Inhibition Has No Effect on the Counterregulatory Response to Hypoglycemia in Subjects with Type 1 Diabetes (T1D)
Published in Diabetes (New York, N.Y.) (01-06-2021)“…Individuals with T1D have an ineffective glucagon response to low glucose levels which predisposes them to episodes of hypoglycemia. SGLT-2 inhibitors (SGLT2i)…”
Get full text
Journal Article -
13
Multimodal Comparisons of Social Phobia Subtypes and Avoidant Personality Disorder
Published in Journal of anxiety disorders (01-05-1999)“…The purpose of the present study was to further clarify the behavioral, physiological, and verbal response of patients with circumscribed social (speech)…”
Get full text
Journal Article -
14
Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects1
Published in Endocrinology (Philadelphia) (01-09-1999)“…Chronic exposure (48 h) to glucosamine resulted in a dose-dependent reduction of basal and insulin-stimulated glucose uptake activities in human skeletal…”
Get full text
Journal Article -
15
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team
Published in Journal of Alzheimer's disease (01-01-2017)“…Alzheimer's disease (AD) drug development is burdened with the current requirement to conduct large, lengthy, and costly trials to overcome uncertainty in…”
Get more information
Journal Article -
16
Mitochondrial H^sup +^-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance
Published in Diabetologia (01-10-2017)“…Aims/hypothesis Mitochondria are important regulators of the metabolic phenotype in type 2 diabetes. A key factor in mitochondrial physiology is the H+-ATP…”
Get full text
Journal Article -
17
Correction to: Mitochondrial H+-ATP synthase in human skeletal muscle: contribution to dyslipidaemia and insulin resistance
Published in Diabetologia (01-12-2018)“…Owing to an oversight, the authors omitted to note that Dr Taub is a co-founder of and equity holder in Cardero Therapeutics…”
Get full text
Journal Article -
18
Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes
Published in Diabetes (New York, N.Y.) (01-02-2000)“…Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. S E Nikoulina , T P Ciaraldi , S Mudaliar , P Mohideen ,…”
Get full text
Journal Article -
19
Role of Glycogen Synthase Kinase-3α in Insulin Action in Cultured Human Skeletal Muscle Cells
Published in Endocrinology (Philadelphia) (01-09-2007)“…An association between glycogen synthase kinase-3 (GSK3) in skeletal muscle and insulin resistance has been demonstrated in type 2 diabetic patients. In…”
Get full text
Journal Article -
20
Impaired Muscle Glycogen Synthase in Type 2 Diabetes Is Associated with Diminished Phosphatidylinositol 3-Kinase Activation
Published in The journal of clinical endocrinology and metabolism (01-09-2001)“…Insulin signaling pathways potentially involved in regulation of skeletal muscle glycogen synthase were compared in differentiated human muscle cell cultures…”
Get full text
Journal Article